Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001178937-23-000037
Filing Date
2023-12-18
Accepted
2023-12-18 18:44:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 20396
  Complete submission text file 0001178937-23-000037.txt   22078
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 (617) 778-2500
RA Capital Nexus Fund, L.P. (Reporting) CIK: 0001780117 (see all company filings)

EIN.: 834533481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Subject) CIK: 0001835268 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40212 | Film No.: 231495142
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)